Entheon Biomedical (XCNQ:ENBI) Total Current Assets : C$0.29 Mil (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Entheon Biomedical's total current assets for the quarter that ended in Feb. 2024 was C$0.29 Mil.

Entheon Biomedical Total Current Assets Historical Data

The historical data trend for Entheon Biomedical's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Total Current Assets Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Total Current Assets

Get a 7-Day Free Trial

1.35

1.16

3.21

0.74

0.40

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Current Assets	Get a 7-Day Free Trial															0.65	0.55	0.42	0.40	0.29

Entheon Biomedical Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Entheon Biomedical's Total Current Assets for the fiscal year that ended in Nov. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.345	+	0.006	+	0	+	0.045
	=	0.40

Entheon Biomedical's Total Current Assets for the quarter that ended in Feb. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.25	+	0.006	+	0	+	0.031
	=	0.29

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Entheon Biomedical (XCNQ:ENBI) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Entheon Biomedical's Liquidation Value for the quarter that ended in Feb. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.25	-	0.051	+	0.75 * 0	+	0.5 * 0
=	0.20

Entheon Biomedical Total Current Assets Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Executives

Brian Jahns

Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines